SAFETY AND EFFICACY OF TOCILIZUMAB (ANTI-IL6R, TCZ) THERAPY IN THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION (CABMR) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS.

被引：0
|
作者：
Puliyanda, D. [1 ]
Kim, I. [2 ]
Choi, J. [2 ]
Haas, M. [2 ]
Zhang, X. [2 ]
Vo, A. [2 ]
Pizzo, H. [1 ]
Jordan, S. [2 ]
机构：
[1] Cedars Sinai Med Ctr, Pediat Nephrol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
PEDIATRIC TRANSPLANTATION | 2017年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
201.5
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Chronic Antibody Mediated Rejection (cABMR) in Pediatric Renal Transplant Recipients.
    Puliyanda, D.
    Kim, I.
    Choi, J.
    Haas, M.
    Zhang, X.
    Vo, A.
    Pizzo, H.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 267 - 268
  • [2] Long Term Safety and Efficacy of Tocilizumab (anti-il6r, Tcz) Therapy in the Treatment of Refractory Chronic Antibody Mediated Rejection (cabmr) in 25 Pediatric Renal Transplant Recipients
    Pearl, M.
    Weng, P.
    Dokras, A.
    Pizzo, H.
    Garrison, J.
    Butler, C.
    Zhang, J. Q.
    Lim, K.
    Reed, E.
    Kim, I.
    Haas, M.
    Zhang, X.
    Ettenger, R.
    Jordan, S.
    Puliyanda, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 323 - 323
  • [3] Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Antibody-Mediated Rejection (ABMR) in Pediatric Renal Transplant Patients
    Steggerda, Justin
    Puliyanda, Dechu
    Todo, Tsuyoshi
    Haas, Mark
    Zhang, Xioahai
    Choi, Jua
    Pizzo, Helen
    Jordan, Stanley
    Kim, Irene
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 52 - 52
  • [4] Extended Experience Using Tocilizumab (Anti-IL6R, TCZ) for the Treatment of Chronic Antibody Mediated Rejection (CABMR).
    Choi, J.
    Aubert, O.
    Louie, S.
    Ammerman, N.
    Vo, A.
    Peng, A.
    Huang, E.
    Najjar, R.
    Puliyanda, D.
    Sethi, S.
    Haas, M.
    Lim, K.
    Loupy, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 326 - 327
  • [5] Saftey & Long Term Outcomes of Tocilizumab (Anti-IL6R, TCZ) Therapy in Treatment of Chronic Antibody Mediated Rejection (CABMR) & Transplant Glomerulopathy (TG) in Highly-HLA Sensitized (HS) Patients (PTs)
    Choi, J.
    Aubert, O.
    Vo, A.
    Loupy, A.
    Haas, M.
    Louie, S.
    Kang, A.
    Peng, A.
    Najjar, R.
    Huang, E.
    Toyota, M.
    Zhang, X.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 308 - 308
  • [6] Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients.
    Kincaide, E.
    Hitchman, K.
    Hall, R.
    Yamaguchi, I.
    Crowther, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 715 - 715
  • [7] Long term tolerability and clinical outcomes associated with Tocilizumab (TCZ) therapy in the treatment of refractory antibody mediated rejection (ABMR) in 25 pediatric renal transplant recipients
    Pearl, Meghan
    Weng, Patricia
    Dokras, Aditi
    Pizzo, Helen Phan
    Garrison, Jonathan
    Butler, Carrie
    Zhang, Jennifer
    Reed, Elaine F.
    Kim, Irene
    Choi, Jua
    Haas, Mark
    Zhang, Xiaohai
    Vo, Ashley
    Chambers, Eileen
    Ettenger, Robert
    Jordan, Stanley C.
    Puliyanda, Dechu
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [8] Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients
    Khairallah, Pascale
    Robbins-Juarez, Shelief
    Patel, Shefali
    Shah, Vaqar
    Toma, Katherine
    Fernandez, Hilda
    Dube, Geoffrey K. K.
    King, Kristen
    Mohan, Sumit
    Husain, Syed Ali
    Morris, Heather
    Crew, Russell John
    CLINICAL TRANSPLANTATION, 2023, 37 (01)
  • [9] Anti-IL6R Therapy (Tocilizumab) Improves Long-Term Patient & Graft Survival in Patients with Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.
    Choi, J.
    Vo, A.
    Haas, M.
    Puliyanda, D.
    Louie, S.
    Peng, A.
    Kahwaji, J.
    Villicana, R.
    Kim, I.
    Mirocha, J.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 350 - 350
  • [10] Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
    Pottebaum, April A.
    Venkatachalam, Karthikeyan
    Liu, Chang
    Brennan, Daniel C.
    Murad, Haris
    Malone, Andrew F.
    Alhamad, Tarek
    TRANSPLANTATION DIRECT, 2020, 6 (04): : E543
12345